- Treatment of renovascular disease with percutaneous stent insertion: long-term outcomes
Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia
Australas Radiol 45:438-43. 2001
..Restenosis was common after 6 months, occurring eventually in 29% of screened patients, but was not shown to affect clinical outcomes. Insertion of renal artery stents is a safe and effective treatment for renal artery stenosis...
- Accelerated progression of calcific aortic stenosis in dialysis patients
Department of Nephrology, Royal Melbourne Hospital, Parkville, Vic, Australia
Nephron Clin Pract 94:c40-5. 2003
..Little data exist on the rate at which aortic stenosis progresses in this patient group...
- Interventions for erythropoietin-resistant anaemia in dialysis patients
Sunil V Badve
Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia, 4102
Cochrane Database Syst Rev 8:CD006861. 2013
..However, about 5% to 10% of patients with ESKD exhibit resistance to ESAs, and observational studies have shown that patients requiring high doses of ESA are at increased risk of mortality...
- Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study
Lawrence P McMahon
Monash University, Melbourne, Australia
BMC Nephrol 13:40. 2012
..Nonetheless, a causative role has not been demonstrated, and this potential relationship requires further appraisal in such a complex patient group...
- The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
Matthew A Roberts
Department of Renal Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
Nephrology (Carlton) 20:140-7. 2015
- Prospective evaluation of aortic stenosis in end-stage kidney disease: a more fulminant process?
1Department of Cardiology, Royal Melbourne Hospital, Melbourne VIC, Australia
Nephrol Dial Transplant 26:1651-5. 2011
..Our aim was to determine whether the increased rate of progression resulted in shorter major event-free (AVR or death) survival as compared to controls...
- Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
Nephrol Dial Transplant 29:406-13. 2014
..The aim of this systematic review is to summarize evidence from randomized controlled trials (RCTs) concerning the benefits and risks of uric acid-lowering therapy on renal outcomes...
- Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk
Nigel D Toussaint
The Royal Melbourne Hospital, Grattan Street, Parkville, VIC 3052, Australia
Nephrology (Carlton) 17:433-44. 2012
..This review outlines the epidemiological and experimental evidence highlighting the relationship between excess phosphate and adverse outcomes, and discusses clinical studies required to address this problem...
- Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand
Sarah L White
George Institute, Sydney, NSW, Australia
Am J Public Health 98:1306-13. 2008
..We sought to determine whether an elevated burden of chronic kidney disease is found among disadvantaged groups living in the United States, Australia, and Thailand...
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
Giovanni F M Strippoli
NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Australia
BMJ 336:645-51. 2008
..To analyse the benefits and harms of statins in patients with chronic kidney disease (pre-dialysis, dialysis, and transplant populations)...
- Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study
George Institute for International Health, PO Box M201, Sydney, Australia, 2050
J Am Soc Nephrol 18:2766-72. 2007
..In conclusion, kidney function should be considered when determining the need for blood pressure lowering therapy in patients with cerebrovascular disease...
- The CARI guidelines. Dialysis adequacy (HD) guidelines
Nephrology (Carlton) 10:S61-80. 2005